11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial by Cameron, David, Prof, Piccart-Gebhart, Martine J, PhD, Gelber, Richard D, PhD, Procter, Marion, PhD, Goldhirsch, Aron, MD, de Azambuja, Evandro, MD, Castro, Gilberto, MD, Untch, Michael, MD, Smith, Ian, MD, Gianni, Luca, MD, Baselga, Jose, MD, Al-Sakaff, Nedal, PhD, Lauer, Sabine, PhD, McFadden, Eleanor, MA, Leyland-Jones, Brian, MBBS, Bell, Richard, MBBS, Dowsett, Mitch, PhD, Jackisch, Christian, MD

Get full text

Relevance of IgE binding to short peptides for the allergenic activity of food allergens by Albrecht, Melanie, MSc, Kühne, Yvonne, MSc, Ballmer-Weber, Barbara K., MD, Becker, Wolf-Meinhard, PhD, Holzhauser, Thomas, PhD, Lauer, Iris, PhD, Reuter, Andreas, PhD, Randow, Stefanie, Falk, Sabine, Wangorsch, Andrea, BSc, Lidholm, Jonas, PhD, Reese, Gerald, PhD, Vieths, Stefan, PhD

Get full text